Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Ann Nucl Med. 2010 Jun;24(5):379-85. doi: 10.1007/s12149-010-0376-8. Epub 2010 May 8.
Early diagnosis and initiating treatment of cardiac sarcoidosis are essential because cardiac involvement is an important prognostic factor. Although there are many reports on the diagnosis of cardiac sarcoidosis, the literature on predicting the efficacy of steroid therapy is very limited. The purposes of this study were to investigate the myocardial washout of (99m)Tc-tetrofosmin (TF), and to evaluate the predictability of left ventricular (LV) functional recovery after steroid therapy in patients with cardiac sarcoidosis.
We performed TF-gated SPECT and echocardiography for ten patients with cardiac sarcoidosis before and after initiating steroid therapy. SPECT images were acquired at 30 min (early images) and 3 h (delayed images) after injection. We calculated the total defect score (TDS) and left ventricular ejection fraction (LVEF). The washout score (WOS) was considered as the difference between the early and delayed TDS. In addition, we defined DeltaLVEF as the change in LVEF after initiating steroid therapy. Furthermore, we analyzed the regional TF myocardial uptake (%uptake) and the regional LV function (wall thickness, WT) by the 20-segment model on polar maps as regional indices. The regional washout (RWO) was defined as the change in %uptake between the early and delayed images in TF SPECT before the therapy. We calculated the improvement factor of the regional LV function as DeltaWT (WT after initiating therapy - WT before the therapy) and investigated the relationships among the indices.
We observed WO in 6 of 10 patients (60%). Decreased WT on echocardiography was observed in only 2 of 6 patients (33.3%) in the WO(+) group and in all 4 patients (100%) in the WO(-) group (p < 0.05). WOS before initiating steroid therapy exhibited a good correlation with DeltaLVEF (r = 0.685, p < 0.05). In the regional analysis, %uptake in the early images and delayed images before therapy did not significantly correlate with DeltaWT. In contrast, RWO before therapy was well correlated with DeltaWT (r = 0.435, p < 0.05).
Our preliminary study shows that there is a relationship between washout of (99m)Tc-tetrofosmin and the LV functional recovery after steroid therapy in patients with cardiac sarcoidosis.
早期诊断和开始治疗心肌肉样瘤对心肌肉样瘤至关重要,因为心脏受累是一个重要的预后因素。尽管有许多关于心肌肉样瘤诊断的报告,但关于预测类固醇治疗效果的文献非常有限。本研究的目的是探讨(99m)Tc-四氮唑(TF)的心肌洗脱,并评估心肌肉样瘤患者类固醇治疗后左心室(LV)功能恢复的预测性。
我们对 10 例心肌肉样瘤患者在开始类固醇治疗前后进行 TF 门控 SPECT 和超声心动图检查。注射后 30 分钟(早期图像)和 3 小时(延迟图像)采集 SPECT 图像。我们计算总缺陷评分(TDS)和左心室射血分数(LVEF)。洗脱评分(WOS)被认为是早期和延迟 TDS 之间的差异。此外,我们将 LVEF 的变化定义为开始类固醇治疗后的 LVEF 变化(DeltaLVEF)。此外,我们通过极地图上的 20 节段模型分析 TF 心肌摄取的局部(%摄取)和局部 LV 功能(壁厚度,WT)作为局部指数。将治疗前 TF SPECT 的早期和延迟图像之间的局部洗脱(RWO)定义为%摄取的变化。我们计算局部 LV 功能的改善因子为 DeltaWT(治疗开始后的 WT - 治疗前的 WT),并研究了这些指数之间的关系。
我们观察到 10 例患者中有 6 例(60%)出现 WO。WO(+)组中仅 2 例(33.3%)和 WO(-)组中所有 4 例(100%)患者在超声心动图上观察到 WT 降低(p < 0.05)。开始类固醇治疗前的 WOS 与 DeltaLVEF 呈良好相关性(r = 0.685,p < 0.05)。在局部分析中,治疗前早期和延迟图像的%摄取与 DeltaWT 无显著相关性。相比之下,治疗前的 RWO 与 DeltaWT 密切相关(r = 0.435,p < 0.05)。
我们的初步研究表明,心肌肉样瘤患者的(99m)Tc-四氮唑洗脱与类固醇治疗后 LV 功能恢复之间存在关系。